Condiciones de salud que tomillo puede ayudar a apoyar.
Thyme tincture has demonstrated potent in vitro activity against Cutibacterium acnes (formerly P. acnes), the primary bacterium driving acne lesions. A Leeds Metropolitan University study found thyme tincture outperformed benzoyl peroxide in killing the acne bacterium. A subsequent PMC-published study formulated thyme essential oil as a nanoemulsion and tested it in an animal acne model with anti-inflammatory outcomes. Clinical human trials remain absent, so the evidence is currently preclinical.
Thyme is exceptionally rich in antioxidant phenolics—rosmarinic acid, thymol, luteolin, apigenin—that demonstrate strong free radical scavenging activity in validated assays. Rosmarinic acid and caffeic acid are predominant phenolic compounds with documented antioxidant capacity in both in vitro and animal models. Thyme extract has been shown to modulate oxidative DNA damage in human lymphocytes.
Thyme (Thymus vulgaris) essential oil, primarily through its constituent thymol, has well-documented in vitro antifungal activity against Trichophyton rubrum and T. mentagrophytes—the main tinea pedis pathogens. A study in Mycoses (2002) confirmed thymol's fungicidal activity against these organisms. A 2011 study confirmed fungistatic activity at concentrations achievable topically. Human clinical RCTs for tinea pedis using thyme preparations are absent.
Thyme (Thymus vulgaris) contains thymol and carvacrol, potent antimicrobials with documented activity against VSC-producing oral pathogens. A published RCT found that thyme mouthwash after periodontal treatment was effective in improving bad breath and gingivitis in gingivitis patients. Traditional use of thyme for oral malodor is well documented across Mediterranean and Moroccan ethnobotany.
Aqueous extracts of Thymus serpyllum (wild thyme) normalized arterial blood pressure in spontaneously hypertensive rats (SHR) in multiple animal studies, attributed to rosmarinic acid's vasodilatory and HO-1-mediated mechanisms. A Frontiers in Nutrition (UCL) review noted these cardiovascular effects have been observed predominantly in rodent models, and controlled clinical trials in humans remain lacking.
Thyme (Thymus vulgaris) has both robust traditional use and meaningful clinical evidence for bronchial health. Clinical studies demonstrate that a combination of thyme and primrose root extract significantly reduced bronchitis symptoms in acute bronchitis patients. Thyme extract relaxes airway smooth muscle (bronchodilation) and its active constituent thymol provides antimicrobial and expectorant effects. A meta-analysis confirmed strong evidence for thyme/ivy/primrose combinations in cough and URTI.
Thyme (Thymus vulgaris) is approved by the German Commission E specifically for symptoms of bronchitis and whooping cough. A large 361-patient double-blind placebo-controlled study found a thyme-primrose root combination significantly enhanced recovery from acute bronchitis. A 2025 three-arm RCT (325 adults) confirmed thyme/primrose non-inferior to ivy extract on Bronchitis Severity Score.
Thyme essential oil (TEO), principally via thymol, exerts well-documented fungistatic and fungicidal activity against Candida albicans and other Candida species in laboratory and preclinical studies. It has shown efficacy against fluconazole-resistant clinical isolates, inhibiting germ tube formation and biofilm development. Evidence is currently in vitro and animal-based; clinical human trials are lacking.
Thyme (Thymus vulgaris) essential oil, rich in thymol and carvacrol, has documented in vitro antifungal activity against Candida albicans through the same membrane-disruption mechanism as oregano oil. Laboratory studies demonstrate activity against Candida biofilms and inhibition of the yeast-to-hypha transition. It is used as a rotation alternative to oregano oil in Candida cleanse protocols.
Animal studies demonstrate that thyme essential oil significantly decreases total cholesterol, LDL, and triglycerides while increasing HDL, effects attributed to antioxidant modulation of lipid metabolism. Thymol's antihyperlipidemic mechanism involves membrane stabilization and modulation of lipoprotein circulating levels. Human clinical data are absent; evidence is preclinical.
Thymol, the major bioactive in thyme, inhibits NF-κB and MAPK signaling pathways, reducing pro-inflammatory cytokines including IL-8, TNF-α, and prostaglandins in multiple in vitro and animal models. Anti-inflammatory and mucus-regulatory effects were confirmed in a rodent pulmonary inflammation model using clinically validated thyme/primula combination. Human evidence is indirect, drawn from clinical bronchitis and dysmenorrhea trials.
Thymol, derived from thyme, is the principal active agent in essential oil mouthwashes such as Listerine and is supported by multiple randomized clinical trials and systematic reviews demonstrating reductions in dental plaque and gingivitis. A dedicated thyme mouthwash RCT found significant improvement in gingival index and halitosis versus controls. The American Dental Association recognizes essential oil mouthwashes containing thymol as effective adjuncts.
A 1998 randomized controlled trial (Archives of Dermatology) tested a topical blend including thyme essential oil for alopecia areata in 86 patients; the active group showed significantly better hair regrowth at seven months. Thyme contains apigenin, a bioflavonoid that downregulates TGF-beta in dermal papilla cells and may benefit androgenic alopecia preclinically. Evidence is limited to one small RCT where thyme was part of a multi-essential oil combination.
Thyme (Thymus vulgaris) is recognized by the EMA and Commission E as a medicinal herb for bronchitis and upper respiratory catarrh. Clinical studies show thyme extract with primrose root speeds recovery from bronchitis. Carvacrol and thymol, its main phenols, act as expectorants, antispasmodics, and antimicrobials in the respiratory tract.
Thyme (Thymus vulgaris) was identified as one of seven botanicals with in vitro anti-borrelia activity against stationary-phase B. burgdorferi in a comprehensive review. Thymol, its primary active constituent, and carvacrol have documented antimicrobial effects against multiple bacterial forms. It appeared in the 2023 University of Maryland review with confirmed anti-borrelia activity, one of the few herbs beyond the Johns Hopkins 7. Research in Antibiotics (2018) also showed essential oils including thyme eradicate persister cells.
Multiple clinical trials from Iran and other countries have compared thyme preparations to ibuprofen for primary dysmenorrhea. A triple-blind RCT (PMC3992233) found Thymus vulgaris reduced dysmenorrhea symptom scores comparably to ibuprofen. The mechanism involves antispasmodic effects on uterine smooth muscle via thymol/carvacrol and inhibition of prostaglandin production.
Thyme (Thymus vulgaris) is one of the best-studied herbs for respiratory mucus, acting as both an expectorant and mucolytic through thymol and carvacrol. A 2021 RCT with 730 participants demonstrated a thyme/ivy combination syrup significantly reduced acute cough and cough severity. ESCOP indications include catarrh of the upper and lower respiratory tract.
Thymol selectively inhibits oral pathogens including Streptococcus mutans, periodontopathogens (P. gingivalis, T. forsythia), and Candida species while disrupting biofilm architecture. This modulates the oral microbiome composition demonstrated in clinical periodontal trials. Thymol is a key ingredient in commercially established oral care products with documented microbiome-modulating effects.
Thyme (Thymus vulgaris) is one of the most consistently cited botanicals for pertussis across traditional Western herbalism and modern phytotherapy. Nicholas Culpeper recorded it as a specific remedy for 'chin-cough' (whooping cough) in children. The German Commission E and EMA HMPC have approved thyme herb for bronchitis and spasmodic cough. Its key constituents thymol and carvacrol exert antispasmodic, antimicrobial, and expectorant effects in pharmacological studies, and a 2006 peer-reviewed review specifically listed thyme as Commission-E-approved and warranting clinical trials for pertussis.
Thyme (Thymus vulgaris) essential oil demonstrated antimicrobial activity against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in EUCAST-standard testing. EMA and German Commission E approved thyme for acute bronchitis. A respiratory infection case report included a Thymus-containing EO mixture that reduced oxygen requirement in RSV pneumonia in a pediatric patient.
Thyme has the strongest clinical evidence base of any of its applications. Multiple randomized, double-blind, placebo-controlled trials support thyme-based herbal medicinal products (thyme/ivy and thyme/primula combinations) for reducing cough frequency, bronchitis severity, and symptom duration in acute upper respiratory tract infections. The German S3 guideline on cough and the WHO both recognize its use.
Thyme contains thymol, a phenolic compound with broad-spectrum antibacterial activity complementary to carvacrol from oregano oil. Thymol is active against gram-positive and gram-negative bacteria relevant to SIBO and enhances carvacrol's antimicrobial effects. Thyme extract is included in herbal SIBO protocols (regenerated.health) and its compounds are documented in SIBO antimicrobial literature.
Thyme (Thymus vulgaris) contains thymol and carvacrol with antimicrobial, expectorant, and mucociliary-stimulating properties for sinus and nasal congestion management. A pharmacognosy review identified thymol as one of five primary bioactives validated for nasal congestion treatment. Thyme is included in a licensed European phytomedicine combination for upper respiratory infections, with promising clinical mechanistic evidence (PMC10537612, 2023).
Thyme essential oil was one of the components in the Prichard 2004 double-blind study (140 adult snorers) where the essential oil blend spray reduced snoring in 82% of users' bed partners versus 44% in placebo. Thyme's active compound thymol has antispasmodic and respiratory-clearing properties. Thyme is traditionally used in folk medicine for respiratory conditions and has become popular specifically for snoring.
Thyme (Thymus vulgaris) is approved by the German Commission E for bronchitis and upper respiratory catarrh, and traditional herbal medicine widely uses it for tonsillitis gargles and teas. A human tonsil epithelial cell study confirmed high phenolic content and anti-inflammatory activity of thyme extracts relevant to streptococcal tonsillitis. Its primary active compound thymol has direct antibacterial activity against Streptococcus.
Thyme (Thymus vulgaris) has Commission E and EMA approval for symptomatic relief of cough and upper respiratory catarrh. Multiple clinical trials of ivy/thyme combination preparations showed significant improvement in bronchitis severity. Its thymol and carvacrol components provide expectorant, spasmolytic, and antimicrobial actions.
Thyme (Thymus vulgaris) contains thymol, carvacrol, and rosmarinic acid with documented antiviral activity against influenza and RSV. EMA and Commission E approve Thymus vulgaris preparations for respiratory tract infections. Clinical evidence includes RCTs for acute bronchitis showing efficacy comparable to antibiotic treatment.
Thyme extracts have demonstrated antimicrobial, antioxidant, and hemostatic properties relevant to wound healing across multiple in vitro evaluations. The antiseptic application of thyme oil to infected wounds is one of its oldest and best-documented traditional uses, and thyme is formally recognized by the German Commission E. Preclinical studies confirm facilitation of tissue repair alongside antimicrobial activity.
Thyme has a well-documented traditional use across European herbal medicine for digestive complaints including flatulence, bloating, indigestion, and abdominal cramps. The WHO monograph and Commission E acknowledge its carminative and antispasmodic applications. Thymol and carvacrol exert smooth muscle relaxant effects in gastrointestinal tissue, providing mechanistic support, though formal human RCTs are absent.
Thyme has been used in traditional European medicine as a topical compress for abscesses and infected skin lesions. Its key compound thymol has well-documented antimicrobial activity. Hot moist thyme compresses are referenced in herbalist literature for ripening and treating abscesses.
Thyme has a long-standing traditional use for asthmatic symptoms and wheezing across European and Middle Eastern folk medicine. Preclinical evidence shows thyme oil modulates Th2 cytokines, IgE, and airway inflammation in an ovalbumin-induced rabbit asthma model. Human clinical trial evidence is absent; thymol's bronchospasmolytic properties support the mechanistic plausibility. Some historical formularies, including the WHO monograph context, mention asthma as a traditional indication.
Thyme (Thymus vulgaris) has been used in European folk medicine as an antiseptic bath treatment and topical compress for skin blisters, particularly foot blisters from friction. Its active constituent thymol is a potent antiseptic with broad-spectrum antibacterial properties. Thyme infusion is added to bath water or applied as a compress to prevent blister infection.
Thyme (Thymus vulgaris) is licensed by the German Commission E for treatment of bronchitis, upper respiratory catarrh, and coughs associated with cold and flu. Thymol and carvacrol have documented expectorant, antispasmodic, and antimicrobial properties. An RCT found thyme-ivy syrup significantly reduced acute bronchitis symptoms vs. placebo. EBSCO lists thyme as a proposed natural treatment for cold and flu.
Thyme (Thymus vulgaris) is a well-established traditional remedy for spasmodic cough, bronchitis, and chronic airway conditions including COPD. Herbal Reality identifies it as a warming expectorant and strong antimicrobial herb with a role in acute COPD exacerbations. Its active constituent thymol has documented mucolytic and antispasmodic properties. The German Commission E has approved thyme leaf for bronchitis.
Wild thyme (Thymus serpyllum) has been traditionally used in Europe and North Africa to treat diarrhea, documented in ethnopharmacological literature and acknowledged in PMC pharmacological reviews. The tannin content of thyme provides astringent action on the intestinal mucosa. Preclinical data support intestinal anti-inflammatory properties relevant to diarrheal pathology.
Thyme essential oil has documented in vitro antifungal activity against dermatophytes and Candida species relevant to skin fungal infections. Traditional European herbal medicine has used diluted thyme oil topically for nail and skin fungal infections for centuries. A naturimedica resource citing pharmacopoeia context specifically notes its application for toenail fungal infections.
Thyme has traditional use in European herbal medicine for gastric complaints including gastritis and gastric ulcers, documented in ethnopharmacological records. Serpylli herba (wild thyme) is traditionally used to treat gastric ulcers in Europe and North Africa per PMC pharmacological literature. Thymol's antimicrobial activity against Helicobacter pylori has been studied preclinically, providing mechanistic support.
Thyme has long been used as a traditional remedy for pleurisy and chest infections, with its essential oils thymol and carvacrol providing documented antimicrobial and anti-inflammatory properties. Traditional herbalist sources list thyme juice and tincture specifically for pleurisy, noting its ability to disinfect and clear mucus from congested airways. Commission E has approved thyme for bronchitis, the most closely related condition with clinical evidence.
Thyme (Thymus vulgaris) is recognized by the European Medicines Agency (EMA) as a traditional herbal medicinal product for sore throat and cough. Its essential oil, rich in thymol and carvacrol, exhibits antimicrobial activity against respiratory pathogens and reduces mucosal inflammation. Commission E monographs support its use for upper respiratory catarrh and throat irritation.
Thyme has traditional use as a urinary antiseptic, referenced in ethnopharmacological literature for cystitis and urethritis. In vitro studies confirm thyme essential oil is active against E. coli and other uropathogens, with synergistic activity when combined with antibiotics. No clinical human trials in UTI patients using thyme alone have been published.
Volver